COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel muscarinic agonists and NMDA antagonists to address serious mental health disorders.
Focus Areas
Recent Investors
Total Raised
Funding round